Unknown

Dataset Information

0

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.

ABSTRACT:

SUBMITTER: De Souza A 

PROVIDER: S-EPMC7604263 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.

De Souza Andre A   Tavora Fabio A FA   Mahalingam Devalingam D   Munster Pamela N PN   Safran Howard P HP   El-Deiry Wafik S WS   Carneiro Benedito A BA  

Frontiers in immunology 20201019

Similar Datasets

Unknown Gossypol Affects Viral Replication by Inhibiting Pseudorabies Virus Adsorption.
| S-EPMC12017124 | biostudies-literature
Unknown CMPK2 restricts Zika virus replication by inhibiting viral translation.
| S-EPMC10150978 | biostudies-literature
Unknown AMP-Activated Protein Kinase Restricts Zika Virus Replication in Endothelial Cells by Potentiating Innate Antiviral Responses and Inhibiting Glycolysis.
| S-EPMC7310572 | biostudies-literature
Unknown Matrix Metalloproteinase 8: Could it Benefit the CAR-T Cell Therapy of Solid Tumors?- a- Commentary on Therapeutic Potential.
| S-EPMC6008262 | biostudies-literature
Unknown Dual Role of a Viral Polymerase in Viral Genome Replication and Particle Self-Assembly.
| S-EPMC6168860 | biostudies-literature
Unknown Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
| S-EPMC7430563 | biostudies-literature
Unknown Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma.
| S-EPMC11846495 | biostudies-literature
Unknown Baicalein suppresses Coxsackievirus B3 replication by inhibiting caspase-1 and viral protease 2A.
| S-EPMC11401470 | biostudies-literature
Unknown MERS-CoV antagonizes PKR activation by inhibiting its condensation at viral replication complexes.
| S-EPMC12393344 | biostudies-literature
Unknown The MOV10 helicase restricts hepatitis B virus replication by inhibiting viral reverse transcription.
| S-EPMC6926444 | biostudies-literature